SONOSCAPE(SZ:300633) Xin Jing Bao·2025-05-16 15:23Group 1 - The core viewpoint of the article indicates that the domestic medical equipment market is beginning to recover, with significant growth in procurement amounts observed in the first four months of the year, and an expected increase in equipment updates starting from Q4 2024 [2][3] - In the first quarter report, the company reported a revenue of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit attributable to shareholders of 8.07 million yuan, down 91.94% year-on-year [2] - The company anticipates rapid revenue growth from its new product lines in minimally invasive surgery and cardiovascular intervention by 2025, which is expected to alleviate profit pressure [2] Group 2 - The company noted that while large-scale procurement plans for medical equipment updates have been announced across provinces for 2024, the actual implementation and final bidding rates are low, with remaining projects expected to be executed in 2025 [3] - The company is responding to the trend of lower winning bid prices in some procurement projects, which may signal a decline in overall industry gross margins, by focusing on high-end products and investing heavily in R&D [3] - The increase in centralized procurement projects is expected to accelerate industry consolidation, with leading brands gaining more market share and domestic brands also increasing their market presence [3]